Prognostic value of inflammatory markers and different treatment regimens in neuroendocrine cervical carcinoma: a retrospective study

Prognostic value of inflammatory markers and different treatment regimens in neuroendocrine cervical carcinoma: a retrospective study

BackgroundNeuroendocrine cervical carcinoma (NECC) is a rare and highly aggressive gynecological tumor, with poor prognosis and limited standardized treatment options. Inflammation plays a significant role in tumor progression, and systemic inflammatory markers such as neutrophil-to-lymphocyte ratio...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mingqin Kuang, Qi Wang, Ying Yu, Changmei Shen, Tao Peng, Meili Li, Xiyun Cheng, Jing Huang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Pharmacology
Subjects:	neuroendocrine cervical carcinoma inflammatory markers prognosis clinical research retrospective study
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1652092/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Systemic immune-inflammatory index predict short-term outcome in recurrent/metastatic and locally advanced cervical cancer patients treated with PD-1 inhibitor
by: Qingqing Chen, et al.
Published: (2024-12-01)

Role of Neoadjuvant Chemotherapy in High-Grade Neuroendocrine Carcinoma of the Uterine Cervix
by: Hyerim Eum, et al.
Published: (2024-07-01)

Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapy
by: Tobias Stemann Lau, et al.
Published: (2025-06-01)

Clinical features and prognostic analysis of 14 cases of appendiceal mixed neuroendocrine-non-neuroendocrine tumors with peritoneal pseudomyxoma
by: Pu Zhang, et al.
Published: (2025-05-01)

Single-cell RNA sequencing highlights the unique tumor microenvironment of small cell neuroendocrine cervical carcinoma
by: Tianyou Wang, et al.
Published: (2025-01-01)

Efficacy Assessment and Prognostic Value of Inflammatory Markers in Patients with Stage IV Acral and Cutaneous Melanoma Receiving PD-1 Inhibitors
by: Zhang Y, et al.
Published: (2025-02-01)

NEUROENDOCRINE CARCINOMA OF THE BREAST: 18 CASES WITH LONG-TERM FOLLOW-UP
by: Enver Özkurt, et al.
Published: (2021-09-01)

Neuroendocrine Tumour as a Diagnostic and Prognostic Criterion for Autoimmune Gastritis
by: S. I. Mozgovoi, et al.
Published: (2020-01-01)

Inflammatory Response Markers as Predictors of Colorectal Cancer Prognosis
by: Minsung Kim, et al.
Published: (2023-12-01)

Searching for New Biomarkers of Neuroendocrine Tumors: A Comparative Analysis of Chromogranin A and Inflammatory Cytokines in Patients with Neuroendocrine Tumors
by: Marlena Budek, et al.
Published: (2024-10-01)

Neuroendocrine carcinoma of left adnexa: A case report of rare histology in female gynecological tract
by: Shrutikant Bhatia, et al.
Published: (2025-01-01)

Insulinoma-Associated Protein 1 (INSM1) Expression in Neuroendocrine Neoplasms: A Newly Discovered Diagnostic Marker
by: Sangita A. Vanik, et al.
Published: (2024-08-01)

Large-Cell Neuroendocrine Carcinoma of the Cervix: Case Report and Literature Review
by: Wing Yu Sharon Siu, et al.
Published: (2025-03-01)

Research progress in inflammatory markers and anti-inflammatory therapies for colorectal cancer
by: Mu Hui, et al.
Published: (2024-06-01)

“Pre-Treatment“ and “Post-Treatment” Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment?
by: Serkan Yaşar, et al.
Published: (2025-06-01)

Prognostic Factors Influencing Postoperative Survival in Patients With Neuroendocrine Carcinoma of the Bladder: A Population‐Based Study
by: Liang Liu, et al.
Published: (2025-03-01)

Brian [18F]FDG PET associations of cervical cancer-related peripheral inflammatory markers
by: Yao Hu, et al.
Published: (2025-06-01)

Analysis of the differences between HPV-independent and HPV-related cervical adenocarcinoma
by: Jing He, et al.
Published: (2025-04-01)

Neuroendocrine carcinoma of gallbladder: A rare entity
by: Manisha Shrestha, et al.
Published: (2023-12-01)

Corrigendum: Analysis of the differences between HPV-independent and HPV-related cervical adenocarcinoma
by: Jing He, et al.
Published: (2025-05-01)

Roles of C-reactive protein and LOX-1 on cancer and myeloid-derived suppressor cells in the progression of uterine cervical cancer
by: Michihide Maeda, et al.
Published: (2025-03-01)

Neuroendocrine tumors of the digestive system: pathologic and molecular characteristics
by: V. V. Delektorskaya
Published: (2015-06-01)

Comparison of proximal and distal gastric neuroendocrine carcinoma based on SEER database
by: Lingjie Kong, et al.
Published: (2024-10-01)

A case of small cell neuroendocrine carcinoma of the ampulla of Vater
by: Hiroharu Ito, et al.
Published: (2020-06-01)

Neuroendocrine characterization into schizophrenia: norepinephrine and melatonin as promising biomarkers
by: Junwei Shen, et al.
Published: (2025-05-01)

Prognostic potential of inflammatory markers in chronic kidney disease patients combined with acute myocardial infarction
by: Peizhu Dang, et al.
Published: (2024-12-01)

Neuroendocrine carcinoma of the cervix: the value of postoperative radiation in early-stage disease
by: Xiaochen Song, et al.
Published: (2025-12-01)

NEUROENDOCRINE TUMORS OF THE CERVIX
by: K. V. Safronova, et al.
Published: (2020-10-01)

Prognostic significance of tumor angiogenesis markers in advanced cervical cancer undergoing chemotherapy
by: I Nyoman Bayu Mahendra, et al.
Published: (2024-12-01)

Prognostic Factors and Management Approaches for Small Nonfunctional Pancreatic Neuroendocrine Tumors: Insights from SEER Data
by: Haiyi Hu, et al.
Published: (2025-07-01)

Prognostic value of neutrophil-lymphocyte ratio in gastroenteropancreatic neuroendocrine neoplasm: a systematic review and meta-analysis
by: Yajie Wang, et al.
Published: (2025-04-01)

Relationship between nutritional-inflammatory markers and postoperative outcomes in ovarian cancer: a retrospective study
by: Ying Zhang, et al.
Published: (2025-03-01)

Cervical Conization and Systemic Inflammatory Markers: The Predictive Value of Neutrophil Percentage to Albumin Ratio (NPAR) to Identify High-Grade Cervical Intraepithelial Neoplasia (CIN)
by: Özbilgeç S, et al.
Published: (2025-04-01)

Neuroendocrine differentiation in prostate cancer
by: Cerović Snežana J., et al.
Published: (2004-01-01)

Preoperative serum inflammatory markers in the prognostic assessment of hepatocellular carcinoma resection in stages I/II
by: Fan Liu, et al.
Published: (2025-08-01)

Mixed neuroendocrine–non-neuroendocrine neoplasm of the ampulla of Vater: a case report
by: Kenjiro Date, et al.
Published: (2023-06-01)

Primary large cell neuroendocrine carcinoma of the urethra: a case report
by: Jianbai Chen, et al.
Published: (2025-02-01)

Neuroendocrine Carcinoma of the Breast – Real versus Mimic
by: Megha Joshi, et al.
Published: (2016-01-01)

Multi-omics analyses construct an inflammatory response based prognostic gene signature for cervical cancer and suggest tumor infiltrating monocytes subgroups as key players
by: Yidong Zhang, et al.
Published: (2025-05-01)

Observation of the effect of intensity-modulated radiotherapy combined with microwave diathermy on tumor marker levels and prognosis in cervical cancer
by: Xiangdong Liu, et al.
Published: (2025-06-01)